Fortress Biotech
FBIO
39 hedge funds and large institutions have $16.3M invested in Fortress Biotech in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 13 closing their positions.
61% more call options, than puts
Call options by funds: $710K | Put options by funds: $442K
3% more capital invested
Capital invested by funds: $15.9M → $16.3M (+$399K)
19% less funds holding
Funds holding: 48 → 39 (-9)
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$611K |
| 2 |
Renaissance Technologies
New York
|
-$595K |
| 3 |
Morgan Stanley
New York
|
-$392K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$389K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$255K |
FBIO Hedge Fund Activity: Q3 2014 in Review
39 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2014, worth a combined $16.3M — up 2.5% from $15.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of FBIO and 4 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 7 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $387K. The largest seller was Susquehanna International Group, cutting an estimated $611K.
- 39 institutional investors held Fortress Biotech (FBIO) as of Q3 2014, down from 48 in Q2 2014.
- Funds reported $16.3M of Fortress Biotech stock for Q3 2014, up 2.5% quarter-over-quarter.
- 4 funds opened new Fortress Biotech positions in Q3 2014 and 13 closed out, a net change of -9 holders.
- The largest Fortress Biotech buyer in Q3 2014 was Hudson Bay Capital Management, an estimated $387K added.
- The largest Fortress Biotech seller in Q3 2014 was Susquehanna International Group, an estimated $611K sold.
Based on aggregated 13F filings for Q3 2014.